Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement
NCT00408239 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 367
Last updated 2011-12-19
Summary
Evaluate the safety and tolerability of escalating oral doses of YM150 in patients undergoing elective primary total knee replacement surgery
Conditions
- Thromboembolism
Interventions
- DRUG
-
YM150
Oral
- DRUG
-
enoxaparin
Sub cutaneous
Sponsors & Collaborators
-
Astellas Pharma Inc
lead INDUSTRY
Principal Investigators
-
Central Contact · Astellas Pharma Inc
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-12-31
- Primary Completion
- 2009-03-31
- Completion
- 2009-03-31
Countries
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
Study Locations
More Related Trials
-
Factor Xa Inhibitor YM150 for the Prevention of Blood Clot Formation in Veins After Scheduled Hip Replacement (ONYX-2)
NCT00353678 ·Status: COMPLETED ·Phase: PHASE2
-
Prevention of Venous Thromboembolism in Subjects Undergoing Hip Fracture Surgery or Surgery in the Lower Extremities
NCT00937911 ·Status: COMPLETED ·Phase: PHASE3
-
Phase IIa Venous Thromboembolism (VTE) Prevention Study In Total Knee Replacement (TKR)
NCT00541320 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study to Evaluate the Safety and Efficacy of YM150 in Patients With Knee Replacement Surgery
NCT00595426 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty
NCT01203098 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 3 Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty
NCT01181102 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
NCT00902928 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
FactOr XIa inhibiTion for the pRevention of venOus Thromboembolism in Patients Undergoing Total Knee Arthroplasty
NCT03276143 ·Status: COMPLETED ·Phase: PHASE2
-
BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery
NCT00097357 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Prevention of Recurrence of Venous Thromboembolism in Patients With a History of Venous Thromboembolism
NCT00937820 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of JNJ-70033093 (BMS-986177) Versus Subcutaneous Enoxaparin in Participants Undergoing Elective Total Knee Replacement Surgery
NCT03891524 ·Status: COMPLETED ·Phase: PHASE2
-
Selective Thromboembolism Prophylaxis After Arthroplasty
NCT03804697 ·Status: COMPLETED ·Phase: NA
-
SHR-2004 for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty
NCT05752461 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty
NCT06825416 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of TAK-442 in Subjects Undergoing Total Knee Replacement
NCT00641732 ·Status: COMPLETED ·Phase: PHASE2
-
Dabigatran Etexilate vs Enoxaparin in Prevention of Venous Thromboembolism (VTE) Post Total Knee Replacement
NCT00152971 ·Status: COMPLETED ·Phase: PHASE3
-
Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery
NCT00452530 ·Status: COMPLETED ·Phase: PHASE3
-
Factor XI inhibiTion for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty
NCT06180889 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Direct Factor Xa Inhibitor YM150 for Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation
NCT00448214 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of TeaRx Xa Factor Direct Inhibitor Versus Enoxaparin as a Venous Thromboembolic Events (VTE) Prevention Following Total Knee Replacement
NCT03088358 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Study Evaluating Alterations in Thrombogenicity and Platelet Reactivity Following Lower Extremity Arthroplasty
NCT01809054 ·Status: COMPLETED ·Phase: PHASE4
-
REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults
NCT07015905 ·Status: RECRUITING ·Phase: PHASE3
-
A Prospective Study in Chinese Patients With Lower Extremity Ankle Fracture of Oral Anticoagulants to Prevent Venous Thromboembolism (VTE)
NCT04128254 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of BIBR 1048 in Prevention of Venous Thromboembolism in Patients With TKR Surgery.
NCT00246025 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery
NCT00306254 ·Status: COMPLETED ·Phase: PHASE2